HCTI Fundamental Analysis - HEALTHCARE TRIANGLE INC

Fundamental Rating

HCTI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. HCTI may be in some trouble as it scores bad on both profitability and health. HCTI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HCTI has reported negative net income.

In the past year HCTI has reported a negative cash flow from operations.

HCTI had negative earnings in 4 of the past 5 years.

In the past 5 years HCTI always reported negative operating cash flow.

1.2 Ratios

HCTI's Return On Assets of -38.89% is on the low side compared to the rest of the industry. HCTI is outperformed by 68.57% of its industry peers.

The Return On Equity of HCTI (-55.49%) is worse than 60.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-38.89%
ROE	-55.49%
ROIC	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HCTI's Gross Margin of 15.18% is on the low side compared to the rest of the industry. HCTI is outperformed by 85.71% of its industry peers.

HCTI's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for HCTI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	15.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HCTI has been increased compared to 1 year ago.

Compared to 5 years ago, HCTI has more shares outstanding

Compared to 1 year ago, HCTI has a worse debt to assets ratio.

2.2 Solvency

HCTI has an Altman-Z score of -1.25. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.

HCTI's Altman-Z score of -1.25 is on the low side compared to the rest of the industry. HCTI is outperformed by 62.86% of its industry peers.

A Debt/Equity ratio of 0.04 indicates that HCTI is not too dependend on debt financing.

HCTI has a Debt to Equity ratio (0.04) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	-1.25

ROIC/WACCN/A

WACC9.08%

2.3 Liquidity

HCTI has a Current Ratio of 2.81. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.

HCTI has a Current ratio (2.81) which is in line with its industry peers.

HCTI has a Quick Ratio of 2.81. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.

HCTI has a Quick ratio (2.81) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.81
Quick Ratio	2.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.50% over the past year.

The Revenue for HCTI has decreased by -45.90% in the past year. This is quite bad

HCTI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.46% yearly.

EPS 1Y (TTM)74.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.17%

Revenue 1Y (TTM)-45.9%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%19.24%

3.2 Future

Based on estimates for the next years, HCTI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.35% on average per year.

Based on estimates for the next years, HCTI will show a very negative growth in Revenue. The Revenue will decrease by -12.97% on average per year.

EPS Next Y-1933.33%

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

EPS Next 5Y43.35%

Revenue Next Year-72.5%

Revenue Next 2Y-36.88%

Revenue Next 3Y-21.81%

Revenue Next 5Y-12.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCTI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as HCTI's earnings are expected to decrease with -34.71% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HCTI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (12/12/2025, 8:00:01 PM)

After market: 2.39 +0.05 (+2.14%)

2.34

-0.12 (-4.88%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)11-13 2025-11-13/bmo

Earnings (Next)N/A N/A

Inst Owners11.61%

Inst Owner Change-96.04%

Ins OwnersN/A

Ins Owner Change0%

Market Cap13.74M

Revenue(TTM)11.87M

Net Income(TTM)-5.67M

Analysts82.86

Price Target5.1 (117.95%)

Short Float %7.28%

Short Ratio0.44

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)233.33%

PT rev (3m)233.33%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-33.58%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-12.28%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.16
P/FCF	N/A
P/OCF	N/A
P/B	1.35
P/tB	3.05
EV/EBITDA	N/A

EPS(TTM)-157.51

EYN/A

EPS(NY)-0.54

Fwd EYN/A

FCF(TTM)-1.51

FCFYN/A

OCF(TTM)-1.41

OCFYN/A

SpS2.02

BVpS1.74

TBVpS0.77

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-38.89%
ROE	-55.49%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	15.18%
FCFM	N/A

ROA(3y)-159.11%

ROA(5y)-96.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.08%

GM growth 5Y3.95%

F-Score3

Asset Turnover0.81

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.81
Quick Ratio	2.81
Altman-Z	-1.25

F-Score3

WACC9.08%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)74.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.17%

EPS Next Y-1933.33%

EPS Next 2Y-142.67%

EPS Next 3Y-34.71%

EPS Next 5Y43.35%

Revenue 1Y (TTM)-45.9%

Revenue growth 3Y-30.78%

Revenue growth 5Y-16.46%

Sales Q2Q%19.24%

Revenue Next Year-72.5%

Revenue Next 2Y-36.88%

Revenue Next 3Y-21.81%

Revenue Next 5Y-12.97%

EBIT growth 1Y54.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-21.3%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-37.45%

OCF growth 3YN/A

OCF growth 5YN/A

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

ChartMill assigns a fundamental rating of 2 / 10 to HCTI.

What is the valuation status of HEALTHCARE TRIANGLE INC (HCTI) stock?

ChartMill assigns a valuation rating of 0 / 10 to HEALTHCARE TRIANGLE INC (HCTI). This can be considered as Overvalued.

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?

HEALTHCARE TRIANGLE INC (HCTI) has a profitability rating of 1 / 10.

HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

What is the valuation status of HEALTHCARE TRIANGLE INC (HCTI) stock?

How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?